Correlation Between Atea Pharmaceuticals and Cronos

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Atea Pharmaceuticals and Cronos at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atea Pharmaceuticals and Cronos into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atea Pharmaceuticals and Cronos Group, you can compare the effects of market volatilities on Atea Pharmaceuticals and Cronos and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atea Pharmaceuticals with a short position of Cronos. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atea Pharmaceuticals and Cronos.

Diversification Opportunities for Atea Pharmaceuticals and Cronos

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Atea and Cronos is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Atea Pharmaceuticals and Cronos Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cronos Group and Atea Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atea Pharmaceuticals are associated (or correlated) with Cronos. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cronos Group has no effect on the direction of Atea Pharmaceuticals i.e., Atea Pharmaceuticals and Cronos go up and down completely randomly.

Pair Corralation between Atea Pharmaceuticals and Cronos

Given the investment horizon of 90 days Atea Pharmaceuticals is expected to under-perform the Cronos. But the stock apears to be less risky and, when comparing its historical volatility, Atea Pharmaceuticals is 1.02 times less risky than Cronos. The stock trades about 0.0 of its potential returns per unit of risk. The Cronos Group is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  201.00  in Cronos Group on August 20, 2025 and sell it today you would earn a total of  41.00  from holding Cronos Group or generate 20.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Atea Pharmaceuticals  vs.  Cronos Group

 Performance 
       Timeline  
Atea Pharmaceuticals 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Atea Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's forward indicators remain relatively invariable which may send shares a bit higher in December 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Cronos Group 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cronos Group are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Cronos is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Atea Pharmaceuticals and Cronos Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Atea Pharmaceuticals and Cronos

The main advantage of trading using opposite Atea Pharmaceuticals and Cronos positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atea Pharmaceuticals position performs unexpectedly, Cronos can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cronos will offset losses from the drop in Cronos' long position.
The idea behind Atea Pharmaceuticals and Cronos Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins